The new service is expected to enable fast delivery of clinical trial images through a web accessible, secure network between clinical sites and Bio-Imaging’s Imaging Core Lab (ICL), increasing efficiency while reducing costs. The service, which is available immediately, has already been deployed for active studies with Bio-Imaging’s major pharmaceutical clients.
AG Mednet’s Clinical Trials Imaging network is reportedly a sophisticated infrastructure designed for investigator sites and trial managers. At the investigator site, a web-enabled agent guides trial managers through a process to send the image studies and data directly to the ICL. The process typically takes minutes, compared to previously used methods that have taken hours or days.
Bio-Imaging’s partnership with AG Mednet is expected to simplify contracting and implementation for its clients to a single line item, as Bio-Imaging manages all of the details.
Mark Weinstein, CEO of Bio-Imaging Technologies, said: “By partnering with AG Mednet, Bio-Imaging Technologies now provides our customers with many key benefits over the manual transport methods commonly used in imaging trials. This partnership increases trial efficiency with faster delivery of the imaging data, enhances data quality with fewer site queries, and reduces cost versus today’s standard global courier shipments.
“As Bio-Imaging can manage all of the logistics to centralize radiologic data and provide expert independent review services for Phase I-IV clinical trials, we now provide a one-stop-shop for today’s medical researchers.”